15 completed, 4 terminated. 19 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 19 | Completed 15, Terminated 4 |
Follow Bracco Diagnostics, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases Gadoxetate disodium, Gadobenate dimeglumine - Oligometastatic Disease, Liver Metastases | Phase 4 | Terminated | University of Colorado, Denver | 10 | 2021-06-22 | 2026-09-25 |
| Thyroid Function of Pediatric Subjects Following Isovue® Administration Isovue - Hypothyroidism | Phase 4 | Terminated | Bracco Diagnostics, Inc | 17 | 2019-03-26 | 2025-07-30 |
| A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA) Iomeron - Aortic Disorders, Carotid Disease | Phase 4 | Completed | Bracco Diagnostics, Inc | 224 | 2015-12-01 | 2017-06-02 |
| Crossover Comparison of MultiHance and Dotarem MultiHance 0.1 mmol/kg, Dotarem, MultiHance 0.05 mmol/kg - Brain Disease | Phase 4 | Completed | Bracco Diagnostics, Inc | 179 | 2014-02-01 | 2017-01-10 |
| Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain gadoteridol, gadobutrol - Brain Disease | Phase 4 | Completed | Bracco Diagnostics, Inc | 229 | 2012-08-01 | 2015-07-01 |
| Kidney Damage in Patients With Normal eGFR Non ionic contrast media comparator - Coronary Artery Stenosis | Phase 4 | Completed | Bracco Diagnostics, Inc | 49 | 2010-12-01 | 2013-09-30 |
| Kidney Damage in Patients With Moderate Fall in eGFR Iopamidol, Iodixanol-320 - Coronary Artery Stenosis | Phase 4 | Completed | Bracco Diagnostics, Inc | 57 | 2010-11-01 | 2020-11-04 |
| Kidney Damage In Patients With Severe Fall In eGFR Iopamidol 370, Iodixanol 320 - Coronary Artery Stenosis | Phase 4 | Terminated | Bracco Diagnostics, Inc | 15 | 2010-11-01 | 2014-03-17 |
| Isovue in Peripheral Digital Subtraction Angiography (DSA) iopamidol, iodixanol - Peripheral Arterial Occlusive Disease | Phase 4 | Completed | Bracco Diagnostics, Inc | 174 | 2010-04-01 | 2013-05-30 |
| Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain MULTIHANCE:, GADOVIST - Brain Lesions | Phase 4 | Completed | Bracco Diagnostics, Inc | 121 | 2009-09-01 | 2012-01-05 |
| Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients Iopamidol injection 76%, iodixanol - Chronic Renal Impairment, Diabetes Mellitus | Phase 4 | Terminated | Bracco Diagnostics, Inc | 23 | 2009-03-01 | 2012-01-26 |
| Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA VISIPAQUE 270, Isovue 250 - Peripheral Arterial Occlusive Disease | Phase 4 | Completed | Bracco Diagnostics, Inc | 33 | 2008-09-01 | 2011-05-09 |
| Comprehensive Cardiothoracic Dual Source CT for the Early Triage of Patients With Acute Chest Pain Comprehensive Cardiothoracic CT arm - Chest Pain Syndrome | Phase 4 | Completed | Massachusetts General Hospital | 59 | 2008-05-01 | 2017-12-22 |
| Multihance at 3 Tesla (3T) in Brain Tumors Multihance, Arm 2 - Magnevist - Brain Tumor | Phase 4 | Completed | Bracco Diagnostics, Inc | 46 | 2006-11-01 | 2020-11-05 |
| Detection of Pulmonary Embolism With CECT Isovue - Pulmonary Embolism | Phase 4 | Completed | Bracco Diagnostics, Inc | 120 | 2006-07-01 | 2008-01-07 |
| A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain Multihance - Brain Pathology | Phase 4 | Completed | Bracco Diagnostics, Inc | 114 | 2006-05-01 | 2008-01-23 |
| Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT) Iopamidol 370 mgI/dL - Kidney Diseases | Phase 4 | Completed | Bracco Diagnostics, Inc | 350 | 2006-01-01 | 2008-01-07 |
| A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography Iopamidol 370 mgI/mL - CIN | Phase 4 | Completed | Bracco Diagnostics, Inc | 400 | 2005-07-01 | 2006-08-18 |
| Patients With Renal Impairment Undergoing CT Iopamidol 370 mgI/mL - Contrast Induced Nephropathy | Phase 4 | Completed | Bracco Diagnostics, Inc | 150 | 2004-11-01 | 2012-02-08 |
Coronary Stenosis (3) · Brain Diseases (2) · Peripheral Arterial Occlusive Disease 1 (2) · Aortic Diseases (1) · Brain Neoplasms (1) · Colorectal Neoplasms (1) · Diabetes Mellitus (1) · Hypothyroidism (1) · Kidney Diseases (1) · Lung Diseases (1) · Peripheral Arterial Disease (1) · Pulmonary Embolism (1) · Renal Insufficiency, Chronic (1)
Iopamidol (8) · gadobenic acid (5) · iodixanol (4) · gadobutrol (2) · Gadolinium DTPA (1) · gadolinium ethoxybenzyl DTPA (1) · gadoterate meglumine (1) · gadoteridol (1) · iomeprol (1)
United States (15) · Canada (3) · China (1)
Gianpaolo Pirovano, MD (3) · Maria Luigia Storto, MD (2) · Marie Morris (2) · Alberto Spinazzi, M.D. (1) · Barry Hogstrom, M. D. (1) · Gianpaolo Priovano, M.D. (1) · Kathleen S Bensel, CNMT (1) · Martin Krix, M.D. (1) · Martin Krix, MD, MSc (1) · Mary Luigia Storto, MD (1) · Nikhil Madhuripan, MD (1) · Steve Sireci, M.D. (1) · Steven N. Sireci, MD (1) · Udo Hoffmann, MD, MPH (1)
P30CA046934 (1)